Home
>
National Drug Code (NDC)
>
Sandostatin LAR Depot Demonstration Kit
Sandostatin LAR Depot Demonstration Kit - 0078-9342-61 - (octreotide acetate)
Drug Information of Sandostatin LAR Depot Demonstration Kit
| Product NDC: | 0078-9342 |
| Proprietary Name: | Sandostatin LAR Depot Demonstration Kit |
| Non Proprietary Name: | octreotide acetate |
| Active Ingredient(s): | & nbsp; octreotide acetate |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sandostatin LAR Depot Demonstration Kit
| Product NDC: | 0078-9342 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021008 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19881101 |
Package Information of Sandostatin LAR Depot Demonstration Kit
| Package NDC: | 0078-9342-61 |
| Package Description: | 1 KIT in 1 KIT (0078-9342-61) * 1 SWAB in 1 PACKAGE * 5 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 SYRINGE |
NDC Information of Sandostatin LAR Depot Demonstration Kit
| NDC Code | 0078-9342-61 |
| Proprietary Name | Sandostatin LAR Depot Demonstration Kit |
| Package Description | 1 KIT in 1 KIT (0078-9342-61) * 1 SWAB in 1 PACKAGE * 5 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 SYRINGE |
| Product NDC | 0078-9342 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | octreotide acetate |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19881101 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
